rs1476464

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001128164.2(ATXN1):​c.-160-63587T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.153 in 152,188 control chromosomes in the GnomAD database, including 2,033 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2033 hom., cov: 32)

Consequence

ATXN1
NM_001128164.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.315

Publications

3 publications found
Variant links:
Genes affected
ATXN1 (HGNC:10548): (ataxin 1) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames. [provided by RefSeq, Nov 2017]
ATXN1 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 1
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.229 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN1NM_001128164.2 linkc.-160-63587T>G intron_variant Intron 6 of 7 ENST00000436367.6 NP_001121636.1
ATXN1NM_000332.4 linkc.-160-63587T>G intron_variant Intron 7 of 8 NP_000323.2
ATXN1NM_001357857.2 linkc.-189-63587T>G intron_variant Intron 7 of 8 NP_001344786.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN1ENST00000436367.6 linkc.-160-63587T>G intron_variant Intron 6 of 7 1 NM_001128164.2 ENSP00000416360.1
ATXN1ENST00000244769.8 linkc.-160-63587T>G intron_variant Intron 7 of 8 1 ENSP00000244769.3

Frequencies

GnomAD3 genomes
AF:
0.153
AC:
23268
AN:
152070
Hom.:
2031
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.233
Gnomad AMI
AF:
0.143
Gnomad AMR
AF:
0.118
Gnomad ASJ
AF:
0.124
Gnomad EAS
AF:
0.0279
Gnomad SAS
AF:
0.0408
Gnomad FIN
AF:
0.111
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.139
Gnomad OTH
AF:
0.142
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.153
AC:
23292
AN:
152188
Hom.:
2033
Cov.:
32
AF XY:
0.149
AC XY:
11082
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.233
AC:
9680
AN:
41488
American (AMR)
AF:
0.117
AC:
1795
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
432
AN:
3470
East Asian (EAS)
AF:
0.0280
AC:
145
AN:
5186
South Asian (SAS)
AF:
0.0410
AC:
198
AN:
4826
European-Finnish (FIN)
AF:
0.111
AC:
1178
AN:
10610
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.139
AC:
9422
AN:
68006
Other (OTH)
AF:
0.140
AC:
296
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
962
1925
2887
3850
4812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.143
Hom.:
260
Bravo
AF:
0.158
Asia WGS
AF:
0.0540
AC:
186
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.4
DANN
Benign
0.82
PhyloP100
-0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1476464; hg19: chr6-16392288; API